Advanced Medicine

In the 20th century, physics and chemistry reshaped the world. Here’s why biology will be the game-changer in the 21st century.

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

How can we maximize the potential and production of potentially life-saving therapies?

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Experts from the BIA got together to discuss how the UK’s biotechnology industry can plug the UK’s worrying skills gap.